Olaparib maintenance therapy stretched out progression-free survival, suggesting a need for germline BRCA1/2 mutation testing in pancreatic cancer patients.
Researchers report lower than expected rates of genetic testing in a study of women with breast and ovarian cancer, MedPage Today reports.
A trio of researchers examines the effects of small and large research teams on their fields, according to the New York Times.
In PLOS this week: statistical approach for integrating eQTL and GWAS data, microRNA signature distinguishes malignant and benign salivary gland tumors, and more.
Run by the daughter of a renowned genetic oncologist, CancerIQ is expanding and raising money as it rolls out its testing management and clinical decision support technology.
In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.
The infringement relates to US patents held by the University of Chicago and exclusively licensed to Bio-Rad.
Three studies encompassing dozens of ancient genomes are offering a closer look at complex historical population spread in North, Central, and South America.
In Genome Biology this week: comparative genomic study of endoderm differentiation, a single-cell sequencing method for small and messenger RNAs, and more.
In Science this week: series of reviews about gene modification, and more.
The chief executive of the National Health Service in England is to call for tumor-agnostic drugs to be "fast-tracked," according to the Times.
Researchers in Australia are sequencing the Wollemi pine tree to try to protect it from extinction, Australia's ABC News reports.
Computerworld ranks Illumina as one of the top midsize organizations to work at in IT.
In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.